Cigna Investments Inc. New Invests $450,000 in Amrize Ltd $AMRZ

Cigna Investments Inc. New bought a new stake in Amrize Ltd (NYSE:AMRZFree Report) during the 3rd quarter, Holdings Channel reports. The firm bought 9,319 shares of the company’s stock, valued at approximately $450,000.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. bought a new stake in Amrize in the 2nd quarter valued at $1,065,029,000. Norges Bank acquired a new stake in shares of Amrize during the second quarter worth $670,915,000. Dodge & Cox acquired a new stake in shares of Amrize during the second quarter worth $622,085,000. JPMorgan Chase & Co. bought a new stake in shares of Amrize in the second quarter valued at about $220,404,000. Finally, Legal & General Group Plc acquired a new position in shares of Amrize in the second quarter valued at about $161,761,000.

Wall Street Analyst Weigh In

AMRZ has been the subject of several analyst reports. Oddo Bhf initiated coverage on shares of Amrize in a research note on Monday, November 3rd. They issued a “neutral” rating for the company. Vertical Research started coverage on shares of Amrize in a report on Tuesday, November 25th. They set a “hold” rating and a $54.00 target price on the stock. Oppenheimer initiated coverage on Amrize in a research note on Tuesday, September 9th. They issued an “outperform” rating and a $62.00 price target for the company. Citigroup raised their price objective on Amrize from $60.00 to $63.00 and gave the stock a “buy” rating in a research note on Monday, November 3rd. Finally, Kepler Capital Markets raised Amrize to a “strong-buy” rating in a report on Tuesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Amrize currently has an average rating of “Moderate Buy” and an average target price of $60.00.

Check Out Our Latest Research Report on AMRZ

Amrize Stock Performance

Shares of AMRZ opened at $55.86 on Wednesday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.97 and a current ratio of 1.45. Amrize Ltd has a 52-week low of $44.12 and a 52-week high of $56.76. The company has a market cap of $30.89 billion and a price-to-earnings ratio of 30.36. The firm has a fifty day simple moving average of $52.44.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.03). The company had revenue of $3.68 billion during the quarter, compared to analyst estimates of $3.49 billion. The firm’s quarterly revenue was up 6.6% compared to the same quarter last year.

Insider Activity at Amrize

In related news, Director Nicholas C. Gangestad bought 2,000 shares of the company’s stock in a transaction dated Wednesday, November 19th. The stock was purchased at an average price of $47.34 per share, with a total value of $94,680.00. Following the completion of the acquisition, the director owned 4,958 shares of the company’s stock, valued at $234,711.72. The trade was a 67.61% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jaime Hill purchased 4,000 shares of Amrize stock in a transaction dated Tuesday, November 4th. The stock was bought at an average price of $50.69 per share, for a total transaction of $202,760.00. Following the completion of the purchase, the insider owned 18,101 shares in the company, valued at $917,539.69. This represents a 28.37% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 65,000 shares of company stock worth $3,399,720 over the last three months.

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.